Intellia Therapeutics Inc. News
After Prime Medicine, What's the Next Gene Editing IPO?
Three privately-held biotech companies could be next in line for making the jump to public markets.
Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape
A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.
Cramer's Mad Money Recap 2/1: Colgate-Palmolive, Stanley Black & Decker
Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.
Intellia Stock Jumps on Progress With Gene-Editing Treatment
'These data open a new era of medicine – one that holds the potential of curing genetic disease,' Intellia said. Its shares are higher.
Intellia Therapeutics Leads Gene-Editing Stock Rally
Intellia Therapeutics rises and other gene-editing stocks follow suit.
5 Top Stock Gainers for Monday: Intellia Therapeutics, QAD, Etsy, Nvidia
Intellia Therapeutics, QAD, Etsy, NRG Energy and Nvidia are five top stock gainers for Monday.
Trading Intellia Therapeutics, ARKG ETF After Breakthrough Data
The genetics space has everyone's attention on Monday as traders look to capitalize on the potential of these stocks. Let's look at a few charts.
Ford Follows Tesla Into EV Price War With Mustang Mach-E Cuts, Production Boost
"We are not going to cede ground to anyone," said Marin Gjaja, COO for Ford Model e.
FedEx Makes Morningstar List of Undervalued Industrial Stocks
The S&P 500 Industrials index returned 3.99% over the past year, compared to a negative return for the S&P 500 overall.
United Airlines Has a Boarding Problem Designed to Punish Budget Flyers
Southwest Airlines has some major problems and passengers may be wary of flying the airline, but its current problems don't tell the whole story.
Nike and Tiffany Tease Plans for Sneakers (With Eye-Popping Price)
The two companies used social media to attract attention about their upcoming release, which shoe fans say could cost plenty.